-
EP0513760
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0513760
| EP0513760 - Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.10.1994 Database last updated on 24.08.2024 | Most recent event Tooltip | 11.10.1994 | Application deemed to be withdrawn | published on 30.11.1994 [1994/48] | Applicant(s) | For all designated states E.R. Squibb & Sons, Inc. P.O.Box 4000 Princeton New Jersey 08543-4000 / US | [N/P] |
| Former [1992/47] | For all designated states E.R. SQUIBB & SONS, INC. P.O.Box 4000 Princeton New Jersey 08543-4000 / US | Inventor(s) | 01 /
Biller, Scott A. 136 Nancy Lane Ewing, NJ / US | 02 /
Magnin, David R. 40 Cottage Court Hamilton, NJ / US | [1992/47] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [1992/47] | VOSSIUS & PARTNER Postfach 86 07 67 D-81634 München / DE | Application number, filing date | 92108073.5 | 13.05.1992 | [1992/47] | Priority number, date | US19910699049 | 13.05.1991 Original published format: US 699049 | [1992/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0513760 | Date: | 19.11.1992 | Language: | EN | [1992/47] | Type: | A3 Search report | No.: | EP0513760 | Date: | 23.12.1992 | Language: | EN | [1992/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 30.10.1992 | Classification | IPC: | A61K31/66, A61K31/665, A61K31/67, A61K31/675 | [1992/47] | CPC: |
A61K31/66 (EP);
A61K31/665 (EP);
A61K31/67 (EP);
A61K31/675 (EP);
A61P3/06 (EP);
A61P9/10 (EP);
C07F9/3843 (EP)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, MC, NL, PT, SE [1992/47] | Title | German: | Verwendung von Biphosphonat-Squalensynthetaseinhibitoren in pharmazeutischen Zusammensetzungen zur Senkung des Cholesterinspiegels | [1992/47] | English: | Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol | [1992/47] | French: | Utilisation de biphosphonates inhibiteurs de la synthèse du squalène dans des préparations pharmaceutiques utiles pour baisser le taux de cholestérol | [1992/47] | File destroyed: | 15.01.2000 | Examination procedure | 18.06.1993 | Examination requested [1993/33] | 12.01.1994 | Despatch of a communication from the examining division (Time limit: M04) | 24.05.1994 | Application deemed to be withdrawn, date of legal effect [1994/48] | 01.07.1994 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1994/48] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.05.1994 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]GB2079285 (SYMPHAR SA); | [X]EP0339237 (SYMPHAR SA [CH]); | [X]EP0356866 (SQUIBB & SONS INC [US]); | [X]EP0418064 (SYMPHAR SA [CH]); | [X]WO8909775 (LEO PHARM PROD LTD [DK]); | [X]WO8703598 (LEO PHARM PROD LTD [DK]); | [XD]US4416877 (BENTZEN CRAIG L [CH], et al) |